SCHEMBL20710

SCHEMBL20710

CCNc1cc[c]cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27513090 0.86 LMNA (0.46)
SCHEMBL1978538 0.80 MAPT (0.41)
SCHEMBL526383 0.80 MAPT (0.58)
SCHEMBL17134071 0.79
SCHEMBL8725842 0.78 MAPT (0.47)
Hydrochloric Acid SCHEMBL9181167 0.77 MAPT (0.56)
Ammonia Solution, Strong SCHEMBL28483632 0.77 MAPT (0.56)
Ammonia Solution, Strong SCHEMBL28486254 0.77 MAPT (0.56)
SCHEMBL694336 0.77 MAPT (0.43)
Water SCHEMBL9462188 0.76 LMNA (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2210 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199667-B Halogen substituted isoindoline compound and application thereof 成都分迪药业有限公司 2024-05-03 CN claimed
WO-2023207241-A1 HALOGEN-SUBSTITUTED ISOINDOLINE COMPOUND AND USE THEREOF 成都分迪药业有限公司 2023-11-02 WO claimed
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2023-10-26 US claimed
CN-116199667-A Halogen substituted isoindoline compound and application thereof 成都分迪药业有限公司 2023-06-02 CN claimed
US-20220202821-A1 SMALL MOLECULE PARG INHIBITORS AND METHODS OF USE THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2022-06-30 US claimed
CN-114213353-A Aryl-oxazole-oxazoline compound and preparation method and application thereof 贵州大学 2022-03-22 CN claimed
EP-3201208-B1 BORONIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 2021-03-24 EP claimed
EP-3201207-B1 BORONIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 2021-02-24 EP claimed
EP-3201205-B1 BORONIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 2020-05-13 EP claimed
US-10640520-B2 Boronic acid derivatives MERCK PATENT GMBH (DE) 2020-05-05 US claimed
WO-1993025524-A1 FUNGICIDAL INDOLE DERIVATIVES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1993-12-23 WO claimed
US-5134150-A Administering diaryl-substituted imidazothiazoles; antiarthritic agents SMITHKLINE BEECHAM CORPORATION (US) 1992-07-28 US claimed
EP-0261602-A2 Pyridine compounds and their use BASF Aktiengesellschaft (DE) 1988-03-30 EP claimed
EP-0214479-A2 Benzimidazol-2-ylpyridinium compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-03-18 EP claimed
EP-0034349-B1 NOVEL PYRIDINECARBOXAMIDE DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF, THE USE OF SAID DERIVATIVES AND A PHARMACEUTICAL COMPOSITION CONTAINING SAME Tanabe Seiyaku Co., Ltd. (JP) 1983-12-14 EP claimed
EP-0032856-B1 2,3-DIHYDROIMIDAZO (1,2-B) PYRIDAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE SYNTHELABO (FR) 1983-02-09 EP claimed
US-4353903-A 2,3-Dihydro-imidazo[1,2-b]pyridazine derivatives, their preparation and use in treatment of depression SYNTHELABO (FR) 1982-10-12 US claimed
US-4332809-A ANTIALLERGENS TANABE SEIYAKU CO., LTD. (JP) 1982-06-01 US claimed
EP-0034349-A2 Novel pyridinecarboxamide derivatives, a process for the preparation thereof, the use of said derivatives and a pharmaceutical composition containing same Tanabe Seiyaku Co., Ltd. (JP) 1981-08-26 EP claimed
EP-0032856-A1 2,3-Dihydroimidazo (1,2-b) pyridazine derivatives, process for their preparation and their therapeutical use SYNTHELABO (FR) 1981-07-29 EP claimed